Try our Advanced Search for more refined results

Indian Officials Conditionally Approve $3.2B Ranbaxy Sale

By Vin Gurrieri ( December 8, 2014, 7:04 PM EST) -- India's antitrust watchdog on Friday cleared the planned $3.2 billion merger of Ranbaxy Laboratories Ltd. and Sun Pharmaceuticals Inc. under the condition that the companies sell off seven products in order to ensure that competition in those drug product markets is not adversely affected by the proposed deal. ...

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!